Latest filing published 27 May 2026 for Edwards Lifesciences Corp, €1.7M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Donald e. Bobo Jr. in Edwards Lifesciences Corp, where the filings describe the role as senior executive. Over a trading history stretching from 4 May 2021 to 27 May 2026, the count stands at 76 filings.
Every open-market trade on record is a sale: 10 sales worth €7.4M. Outside the open market, there are 13 share grants and 52 option exercises. In 2026 alone, the filings show no purchases and 4 sales.
The latest filing, published on 27 May 2026, reports an open-market sale of €1.7M in Edwards Lifesciences Corp. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 76 declarations